Om

BioStem Technologies Inc. is a biotechnology company focused on developing, manufacturing, and commercializing placental-derived allografts for advanced wound care and regenerative therapies. BioStem Technologies Inc. provides tissue-based solutions used in surgical and wound care settings, with products designed to support soft tissue coverage and repair. Its portfolio includes structural tissue allografts and human connective tissue matrices such as Vendaje, Vendaje AC, Vendaje OPTIC, American Amnion, and American Amnion AC. The company also uses its proprietary BioRetain processing method to preserve the natural properties of perinatal tissue while producing its biologic products. BioStem Technologies Inc. serves clinicians and healthcare providers across specialties where tissue repair and regenerative medicine are used, making it a specialized player in the biologics and wound care market.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I BIOSTEM TECHNOLOGIES MED ENDAVU: Køb BioStem Technologies ($0JQ) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i BioStem Technologies, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.